Clostridium perfringens Type A in Beef Calves

Overview

Clostridium perfringens Type A is an anaerobic bacterium that naturally exists in the intestinal tract of cattle. Under certain conditions — sudden feed changes, milk or grain overconsumption, stress, or digestive disturbances — the bacteria can multiply rapidly and produce toxins that damage the intestinal lining. Young beef calves are especially vulnerable, and cases often occur with little warning.

Clinical Signs

Producers should watch for:

Lethargy and poor appetite
Abdominal discomfort and bloating
Diarrhea, which may contain blood
Dehydration and weakness
Sloshy bellies with lots of abdominal fluid

Some calves may be found dead without showing obvious clinical signs, making early detection and identification important. Obtaining an accurate veterinary diagnosis or performing a postmortem exam is important to confirm the cause.

Treatment

Treatment is most effective when started immediately. We recommend:

One pint of mineral oil, given orally
Penicillin G at 10 mL per 100 lbs body weight given orally
Banamine (flunixin meglumine) pour-on at 3 ml per 100 lbs body weight or Meloxicam, given orally
Oral fluids to correct dehydration and electrolyte loss using Complete Dehydration Treatment electrolytes.

Because this disease progresses rapidly, delays in treatment often reduce the chance of recovery.

Prevention and Management

Good management practices are an important defense:

Introduce dietary changes gradually
Avoid overfeeding
Maintain consistent temperature and mixing conditions if milk replacer is being used
Reduce stress during handling and weaning
Maintain clean feeding areas

Vaccination Strategy

We have had excellent results utilizing autogenous Clostridium perfringens Type A vaccines. These can be standalone 2 ml formulations or concentrated antigens that can be added to other commercial vaccines such as Vision 7 or Vision CD. Work with one of our PLS veterinarians before implementing a vaccination protocol.

There have recently been Clostridium perfringens Type E isolates reported in the veterinary community. This strain has a different toxin profile, and Type E is often included in vaccines for overeating disease. Historically, producers considered Clostridium perfringens Type C and Type D as the primary cause of overeating disease; however, when diagnostics are performed, Types A and E are more commonly identified.

The timing of clinical disease onset dictates the vaccination strategy:

Early in calfhood: vaccinate the cow, with the goal of maximizing colostral antibody protection to the calf
If the clinical signs occur at 30–60 days of age: give injectable vaccines directly to the calf

For more specific questions, please reach out to our team at Profectus Livestock Solutions.

Profectus Livestock Solutions

Office 507-343-0386

Mobile 507-360-1365

< Older Post

Intranasal Vaccines: Protection Where Respiratory Disease Starts

By Brian Dorcey, DVM — Profectus Livestock Solutions • September 9, 2026

Respiratory pathogens enter through the nose, so it makes sense to put the vaccine there as well. An intranasal IBR-BRSV-PI3 product builds immunity directly on the lining of the nose and upper airway — the first place those organisms land. There are two good reasons to keep one in your program. The first is that they work in young calves. Antibodies a calf picks up from colostrum will tie up most of an injectable modified-live vaccine before it has a chance to do its job. Intranasal products largely get around that, so even a day-old calf will respond to one. The second reason is speed. You get a local immune response within a few days rather than several weeks, which is exactly what you want when calves are stressed and facing heavy exposure. That's why they fit well at birth or at branding, at arrival processing on light, high-risk calves, ahead of shipping or commingling, and during an active outbreak when you need protection working now. High-risk cattle at arrival This is where an intranasal earns its keep in a yard. On light, auction-sourced, commingled calves, you usually have no idea what they've had, when they had it, or how much protection is left. Some are still carrying maternal antibody, some aren't, and you can't sort them at the chute. An intranasal works either way, which takes the guesswork out of that first processing. The timing lines up too. Those calves are typically already incubating something by the time they come off the truck, and they'll break in the first week or two. A vaccine that starts working in days rather than weeks is worth a great deal in that window. Where they stop What they will not do is cover a calf for the whole year. Duration of immunity is short — plan on a few months. Think of an intranasal as a bridge that carries a calf to weaning, preconditioning, or revaccination in good shape, then let an injectable modified-live build the lasting protection from there. You're layering the two, not trading one for the other. That's really the protocol question: not whether to use one, but where it sits on the calendar. Build backward from weaning and let the intranasal cover the early gap. One reminder on handling — these are live products, so keep them cold, mix only what you'll use within the hour, and make sure the full dose stays in the nostril. Give us a call and we'll work it into your protocol.